Centennial Bank AR Sells 75 Shares of The Allstate Co. (NYSE:ALL)

Centennial Bank AR trimmed its position in The Allstate Co. (NYSE:ALL) by 4.8% during the third quarter, HoldingsChannel.com reports. The firm owned 1,500 shares of the insurance provider’s stock after selling 75 shares during the quarter. Centennial Bank AR’s holdings in Allstate were worth $284,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. Forum Financial Management LP boosted its position in Allstate by 1.4% during the 3rd quarter. Forum Financial Management LP now owns 9,679 shares of the insurance provider’s stock worth $1,836,000 after acquiring an additional 131 shares during the last quarter. Angeles Wealth Management LLC acquired a new position in Allstate during the third quarter worth $254,000. Janney Montgomery Scott LLC grew its position in Allstate by 18.4% in the third quarter. Janney Montgomery Scott LLC now owns 51,032 shares of the insurance provider’s stock valued at $9,678,000 after purchasing an additional 7,940 shares in the last quarter. Carmichael Hill & Associates Inc. increased its stake in Allstate by 15.0% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider’s stock valued at $87,000 after buying an additional 60 shares during the last quarter. Finally, Janney Capital Management LLC increased its position in shares of Allstate by 2.5% in the third quarter. Janney Capital Management LLC now owns 20,160 shares of the insurance provider’s stock valued at $3,823,000 after acquiring an additional 486 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

ALL has been the topic of several analyst reports. Roth Mkm reaffirmed a “buy” rating and set a $200.00 price target on shares of Allstate in a research report on Wednesday, August 14th. Bank of America increased their price target on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a report on Friday, October 18th. Raymond James boosted their price objective on Allstate from $205.00 to $220.00 and gave the stock a “strong-buy” rating in a report on Friday, October 4th. Piper Sandler increased their target price on Allstate from $188.00 to $196.00 and gave the stock an “overweight” rating in a research note on Friday, August 16th. Finally, Keefe, Bruyette & Woods upped their price objective on Allstate from $199.00 to $208.00 and gave the company an “outperform” rating in a report on Monday, August 12th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $207.19.

Insider Activity

In related news, EVP Elizabeth Brady sold 49,481 shares of the business’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the sale, the executive vice president now owns 19,163 shares in the company, valued at $3,431,901.67. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $179.09, for a total value of $8,861,552.29. Following the completion of the transaction, the executive vice president now owns 19,163 shares in the company, valued at $3,431,901.67. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares in the company, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 192,530 shares of company stock worth $34,967,665. Insiders own 1.80% of the company’s stock.

Allstate Stock Down 1.3 %

ALL stock opened at $184.15 on Monday. The firm has a 50-day moving average price of $188.87 and a 200-day moving average price of $175.32. The Allstate Co. has a 12 month low of $127.93 and a 12 month high of $198.79. The company has a current ratio of 0.40, a quick ratio of 0.36 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $48.76 billion, a P/E ratio of 11.93, a price-to-earnings-growth ratio of 1.88 and a beta of 0.48.

Allstate (NYSE:ALL) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating the consensus estimate of $2.20 by $1.71. The business had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The firm’s revenue was up 14.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.81 EPS. As a group, equities research analysts anticipate that The Allstate Co. will post 14.16 EPS for the current fiscal year.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.